Tower Research Capital (TRC)’s Presbia PLC Ordinary Shares LENS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-300
Closed -$1K 4513
2017
Q2
$1K Buy
+300
New +$837 ﹤0.01% 2616
2016
Q4
Sell
-796
Closed -$4K 5124
2016
Q3
$4K Buy
796
+372
+88% +$1.75K ﹤0.01% 2802
2016
Q2
$2K Buy
424
+407
+2,394% +$1.75K ﹤0.01% 4110
2016
Q1
$0 Sell
17
-2,688
-99% -$12.7K ﹤0.01% 5865
2015
Q4
$14K Buy
2,705
+2,239
+480% +$11.7K ﹤0.01% 1765
2015
Q3
$3K Sell
466
-2,396
-84% -$15.9K ﹤0.01% 3285
2015
Q2
$24K Buy
2,862
+2,754
+2,550% +$22.6K ﹤0.01% 1958
2015
Q1
$1K Buy
+108
New +$792 ﹤0.01% 4346

Other funds holding LENS

Tower Research Capital (TRC)'s LENS Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of Presbia PLC Ordinary Shares (LENS) in Q3 2017, closing a stake of 300 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in LENS in Q1 2015 and held it in 8 quarters. The position peaked at $24K in Q2 2015. 7 funds tracked by Wall St. Rank hold LENS as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining Presbia PLC Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 300 Presbia PLC Ordinary Shares shares in Q3 2017, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Presbia PLC Ordinary Shares in Q1 2015 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Presbia PLC Ordinary Shares position peaked at $24K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Presbia PLC Ordinary Shares as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.